Clinical Trial Update: Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail [Phase 2]

View source ↗

Summary

Phase 2, single-arm study evaluating the safety and efficacy of combining Interleukin-2 with a PD-1 monoclonal antibody and CAPOX as neoadjuvant therapy for mid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Interleukin-2 (interleukin-2)
• OXALIPLATIN (Oxaliplatin)
• PD-1 monoclonal antibody

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Locally Advanced Rectal Adenocarcinoma | Phase 2 | Status: COMPLETED